Orexo AB v. Actavis Elizabeth LLC
1:14-cv-00829
Overview
Parties
Defendant
Actavis Elizabeth LLC Operating Company
Represented By
8 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Actavis Inc. Operating Company
Represented By
1 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Plaintiff
Orexo AB NPE (Individual / Inventor)
Represented By
4 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Barnes & Thornburg LLP
1000 N. West Street, Suite 1500, Wilmington, DE 19801
Counter Defendant
Orexo US Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Barnes & Thornburg LLP
1000 N. West Street, Suite 1500, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,454,996 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2013019597 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,761,910 B1 | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2000016750 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 2004021385 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8454996
Pharmaceutical composition for the treatment of acute disorders
|
Filed: 2011-11-22
Issued: 2013-06-04
|
Active (5.0 yrs remaining)
Expires: 2031-11-22
|
|
|
US8470361
Non-abusable pharmaceutical composition comprising opioids
|
Filed: 2007-12-03
Issued: 2013-06-25
|
Active (3.5 yrs remaining)
+901d PTA
Expires: 2030-05-22
|
|
|
US8658198
Non-abusable pharmaceutical composition comprising opioids
|
Filed: 2013-03-13
Issued: 2014-02-25
|
Active (6.3 yrs remaining)
Expires: 2033-03-13
|
|
|
US8940330
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
|
Filed: 2012-09-18
Issued: 2015-01-27
|
Active (5.8 yrs remaining)
Expires: 2032-09-18
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
35
Dispositive
0
Granted
0
Denied
0
Pending / Review
26
Motions by Category
Key Dispositive Motions & Rulings